Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: January 29, 2022

DrugPatentWatch Database Preview

CAPASTAT SULFATE Drug Patent Profile

Email this page to a colleague

« Back to Dashboard

When do Capastat Sulfate patents expire, and what generic alternatives are available?

Capastat Sulfate is a drug marketed by Akorn and is included in one NDA.

The generic ingredient in CAPASTAT SULFATE is capreomycin sulfate. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the capreomycin sulfate profile page.

Drug patent expirations by year for CAPASTAT SULFATE

See drug prices for CAPASTAT SULFATE

Pharmacology for CAPASTAT SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for CAPASTAT SULFATE

US Patents and Regulatory Information for CAPASTAT SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn CAPASTAT SULFATE capreomycin sulfate INJECTABLE;INJECTION 050095-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.